(August 28, 2023, 1:36 PM EDT) -- WASHINGTON, D.C. — A panel of the District of Columbia Circuit U.S. Court of Appeals ruled Aug. 25 that allegations by Federal Trade Commission drugmakers violated antitrust law by the terms of a 2017 settlement in a breach of contract action fail to state a claim....